ROCK1 and central nervous system cancer: In addition, miR-135a is abnormally down-regulated in gastric cancer, glioma, endometrial cancer and other tumors, while ROCK1 is also abnormally over-expressed in osteosarcoma, hepatocellular carcinoma, retinoblastoma and other cancers.